MIRA Pharmaceuticals, Inc. Equity Method Investment, Quoted Market Value
MIRA Pharmaceuticals, Inc. (MIRA) had Equity Method Investment, Quoted Market Value of $4.50 million as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes
us-gaap:EquityMethodInvestmentQuotedMarketValue · last filed 2026-03-31
- 2025-12-31: Equity Method Investment, Quoted Market Value $4.50M.
- 2025-09-30: Equity Method Investment, Quoted Market Value $87.00K.
- 2025-06-30: Equity Method Investment, Quoted Market Value $87.00K.
- 2024-12-31: Equity Method Investment, Quoted Market Value $2.79M.
| Period end | Equity Method Investment, Quoted Market Value |
|---|---|
| 2025-12-31 | $4.50M 10-K · filed 2026-03-31 |
| 2025-09-30 | $87.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $87.00K 10-Q · filed 2025-08-14 |
| 2024-12-31 | $2.79M 10-K · filed 2026-03-31 |
| 2024-09-30 | $1.20M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.10M 10-Q/A · filed 2024-08-16 |
| 2024-03-31 | $800.00K 10-Q · filed 2025-05-14 |
| 2023-12-31 | $2.75M 10-K · filed 2024-04-01 |
| 2023-09-30 | $2.75M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |